European doctor’s continuing medical education perceptions – Survey results

This study was centred around continuing medical education for both secondary and primary care doctors and asked what role the pharmaceutical industry should play. It aimed to answer the following question: Are doctors getting what they need?

Over 1,500 European physicians from our panel participated in this study from wide range of specialties including general practice, cardiology, neurology, rheumatology, endocrinology and infectious diseases.

You can access the results of the study below.



    1. Thank you very much for your comment. We are glad to hear that our content is interesting and relevant for our doctors and readers! Thank you. The M3 Global Research team.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.